An International Journal of Otorhinolaryngology Clinics

Register      Login

VOLUME 15 , ISSUE 2 ( May-August, 2023 ) > List of Articles

CASE REPORT

Inflammatory Pseudotumor of the Nasopharynx: An Unusual Diagnosis of a Destructive Skull Base Lesion

Filipa Ferreira, Sílvia Alves, Ricardo Nuno Pestanudo São Pedro, Cristina Marques

Keywords : Case report, Inflammatory pseudotumor, Nasopharynx, Skull base

Citation Information : Ferreira F, Alves S, Pedro RN, Marques C. Inflammatory Pseudotumor of the Nasopharynx: An Unusual Diagnosis of a Destructive Skull Base Lesion. Int J Otorhinolaryngol Clin 2023; 15 (2):81-83.

DOI: 10.5005/jp-journals-10003-1481

License: CC BY-NC 4.0

Published Online: 21-12-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Abstract

Aim: To describe a rare case of nasopharyngeal inflammatory pseudotumor (IPT) with skull base invasion. Background: Inflammatory pseudotumor is a nonneoplastic lesion characterized by fibrosis and inflammation. It can be locally aggressive and resemble malignancy and extranodal lymphoma. It has been described in nearly every anatomic site throughout the body. Although rare, the involvement of the skull base is associated with more aggressive behavior. Case description: The authors present the case of a 63-year-old male with a 3-month history of right otorrhea, headache, and facial pain in the sensitive territory of the right trigeminal nerve (V3). Magnetic resonance imaging (MRI) showed an infiltrative lesion of the posterior wall of the nasopharynx with poorly defined limits, extended deep into the retropharyngeal and prevertebral space, with bone erosion of the occipital clivus and petrous apex. The patient performed three biopsies of the nasopharynx suggestive of a fibroinflammatory process. Inflammatory pseudotumor was diagnosed and the patient did a long course of high-dose systemic corticotherapy with good clinical and radiological response. Conclusion: Biopsy is essential for the diagnosis of IPT, although it usually just shows inflammatory changes. Magnetic resonance imaging features of this entity are ill-defined lesions with local infiltration, hypointensity on T2-weighted sequences, and weak contrast enhancement, usually with an absence of cervical lymphadenopathies. The treatment of IPT involving the skull base has been controversial but can include corticotherapy and radiotherapy. Clinical significance: This case report highlights the relevance of including IPT in the differential diagnosis of infiltrative nasopharyngeal and skull base lesions, especially when biopsies and cultures are negative.


HTML PDF Share
  1. Lee DK, Cho YS, Hong SH, et al. Inflammatory pseudotumor involving the skull base: Response to steroid and radiation therapy. Otolaryngol Head Neck Surg 2006;135(1):144–148. DOI: 10.1016/j.otohns.2006.01.016.
  2. Gadde J, Franck B, Liu X, et al. Inflammatory pseudotumor of the nasopharynx with spread along the trigeminal nerve. Am J Otolaryngol 2013;34(3):252–254. DOI: 10.1016/j.amjoto.2012.11.013.
  3. Cho KS, Kim HJ, Lee CH, et al. Nasopharyngeal inflammatory pseudotumor showing abducens nerve palsy. Auris Nasus Larynx 2011;38(4):543–546. DOI: 10.1016/j.anl.2010.12.005.
  4. De Vuysere S, Hermans R, Sciot R, et al. Extraorbital inflammatory pseudotumor of the head and neck: CT and MR findings in three patients. AJNR Am J Neuroradiol 1999;20(6):1133–1139. PMID: 10445457.
  5. Chwang WB, Jain R, Narayan A, et al. Inflammatory pseudotumor of the nasopharynx and skull base: Mimicking an aggressive neoplasm or infection. Arch Otolaryngol Head Neck Surg 2012;138(8):765–769. DOI: 10.1001/archoto.2012.1540.
  6. Choi SY, Yu IK, Han MH, et al. Fibrosing inflammatory pseudotumor of the nasopharynx: MR features and histopathologic correlation. Eur J Radiol 2009;72(2):274–277. DOI: 10.1016/j.ejrad.2008.07.026.
  7. Lu CH, Yang CY, Wang CP, et al. Imaging of nasopharyngeal inflammatory pseudotumours: Differential from nasopharyngeal carcinoma. Br J Radiol 2010;83(985):8–16. DOI: 10.1259/bjr/98400347.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.